BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 3, 2014
View Archived Issues
Sinovac files to advance proprietary H7N9 vaccine to clinical trials in China
Read More
Aerie begins dosing in phase IIb study of combination product for glaucoma or ocular hypertension
Read More
Radiotracer [18F]VM-4-037 evaluated in phase II renal cancer study
Read More
Evidence of activity seen with MPX in phase I prostate cancer study
Read More
Roche discloses novel mGlu5 receptor positive allosteric modulators
Read More
Scripps Florida awarded grant to develop new lung cancer treatments
Read More
Boehringer Ingelheim and Duke Clinical Research Institute form partnership for IPF
Read More
Miraculins and Alere shift focus of endoglin program
Read More
Actelion's Opsumit now available in Germany for PAH
Read More
XBiotech and EMA agree on phase III registration study for Xilonix
Read More
Vanda's Hetlioz becomes first FDA-approved treatment for non-24-hour sleep-wake disorder
Read More
Taxis reports development and preclinical characterization of orally available bactericidal prodrugs
Read More
French researchers design new gene sequences for DMD
Read More
3D pluripotent stem cell culture system defined
Read More
PsychoGenics obtains license to mouse model for the study of neurodegenerative diseases
Read More
Alethia Biotherapeutics patents new humanized MAbs for bone disorders
Read More
Enanta Pharmaceuticals reports results from four interferon-free studies in HCV infection
Read More
Identification of a small-molecule lysyl-tRNA synthetase inhibitor that prevents metastasis
Read More
Phase III trial of Eisai's lenvatinib meets primary endpoint in treatment of thyroid cancer
Read More
Stelic Institute & Co. divulges novel siRNAs for gastrointestinal disorders
Read More
Daiichi Sankyo updates progress of third quarter of fiscal 2013
Read More
Genmab prepares new antibodies for cancer and other disorders
Read More
Bionomics reports encouraging results from phase I/II trial of BNC-105 in ovarian cancer
Read More
European Commission grants orphan drug designation to Hybrigenics' inecalcitol for CLL
Read More
Eisai set to launch vascular embolization device DC Bead in Japan
Read More